SIRT1 Expression Is Associated With Cell Proliferation in Angiosarcoma

被引:5
作者
Chosokabe, Motohiro [1 ]
Noguchi, Akira [1 ,2 ]
Hoshikawa, Masahiro [1 ]
Masuzawa, Mikio [3 ]
Takagi, Masayuki [1 ]
机构
[1] St Marianna Univ, Dept Pathol, Sch Med, Kawasaki, Kanagawa, Japan
[2] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Diagnost Pathol, Toyama, Japan
[3] Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa, Japan
关键词
SIRT1; angiosarcoma; cell proliferation; POOR-PROGNOSIS; HISTONE DEACETYLASE; REGULATES SIRT1; CANCER; SARCOMA; DBC1; ESTABLISHMENT; METABOLISM; SENESCENCE; INHIBITOR;
D O I
10.21873/anticanres.13223
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Angiosarcoma is a rare and aggressive soft tissue sarcoma with poor prognosis. Chemotherapy and radiotherapy do not improve the prognosis. SIRT1, a class III histone deacetylase, is up-regulated in many malignant tumours. This study aimed at exploring the role of SIRTl in angiosarcoma. Materials and Methods: The effect of suppressing SIRT1 expression with siRNA on the proliferation and invasion ability of ISO-HAS-B angiosarcoma cells was investigated. Additionally, SIRT1 expression in tissues from surgical specimens was immunohistochemically evaluated and compared to that from benign tumours. Results: Suppression of SIRT1 expression by siRNA resulted in the down-regulation of cell growth, proliferation, migration, and invasion. An immunohistochemical analysis disclosed that SIRT1 expression in angiosarcoma was stronger than that in haemangioma. Conclusion: SIRT1 may be involved in the invasive proliferation and malignant transformation of angiosarcoma, and may be considered a future target for angiosarcoma therapy.
引用
收藏
页码:1143 / 1150
页数:8
相关论文
共 40 条
  • [1] Allred DC, 1998, MODERN PATHOL, V11, P155
  • [2] Altered sirtuin expression is associated with node-positive breast cancer
    Ashraf, N.
    Zino, S.
    MacIntyre, A.
    Kingsmore, D.
    Payne, A. P.
    George, W. D.
    Shiels, P. G.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (08) : 1056 - 1061
  • [3] Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862
  • [4] Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma
    Cha, Eun Jung
    Noh, Sang Jae
    Kwon, Keun Sang
    Kim, Chan Young
    Park, Byung-Hyun
    Park, Ho Sung
    Lee, Ho
    Chung, Myoung Ja
    Kang, Myoung Jae
    Lee, Dong Geun
    Moon, Woo Sung
    Jang, Kyu Yun
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (13) : 4453 - 4459
  • [5] Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses
    Chen, WY
    Wang, DH
    Yen, RWC
    Luo, JY
    Gu, W
    Baylin, SB
    [J]. CELL, 2005, 123 (03) : 437 - 448
  • [6] Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
    Cheng, HL
    Mostoslavsky, R
    Saito, S
    Manis, JP
    Gu, YS
    Patel, P
    Bronson, R
    Appella, E
    Alt, FW
    Chua, KF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) : 10794 - 10799
  • [7] Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO
  • [8] 2-3
  • [9] Regulation of FoxO transcription factors by acetylation and protein-protein interactions
    Daitoku, Hiroaki
    Sakamaki, Jun-ichi
    Fukamizu, Akiyoshi
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2011, 1813 (11): : 1954 - 1960
  • [10] Sirtuins:: The 'magnificent seven', function, metabolism and longevity
    Dali-Youcef, Nassim
    Lagouge, Marie
    Froelich, Sebastien
    Koehl, Chrstian
    Schoonjans, Kristina
    Auwerx, Johan
    [J]. ANNALS OF MEDICINE, 2007, 39 (05) : 335 - 345